2nd Annual Oligonlucleotide-Based Therapeutics Summit

December 8-10, 2026

Join us as we explore the cutting edge of oligonucleotide therapeutics. This will be a deep dive into GalNAc and TfR to engineer better therapeutic solutions.

  • Dates

    December 8-10, 2026

  • Location

    Aloft Boston Seaport District
    Boston, MA, USA

  • Attendance

    37 Companies. 3 Days of Content. 18 Speakers.

  • Key Sessions
    • Jiabao Zhang, Senior Scientist, Biogen — From Novel ASO Chemistry to Scalable Manufacturing; Overcoming Emerging Process & Safety Challenges
    • Qian Chen, NanoDe Therapeutics — Interrogating the Depot Effect & Accumulation of siRNA & ASOs to Improve Safety, Enable Sustained Release & Extend Dosing Intervals
    • Thomas Ormsby, University of Massachusetts Medical School — Enabling Targeted Muscle Delivery Through Aptamer-siRNA Conjugates Beyond Antibody Conjugates
  • Why Oligonucletide-Based Therapeutics?

    This conference will detail the practical framework for ligand selection and benchmarking blood-brain barrier engineering. It also guides CMC/manufacturing decision-making and looks at emerging strategies for oligonucleotide delivery.